Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

The weeks following the ASCO Annual Meeting always feel like a bit of a reset, as we emerge energized from connecting with friends and colleagues.
"If you are young researcher in an LMIC trying to launch your own career, I highly recommend building collaborations and networks with oncologists around the globe," said Dr. Khalid El Bairi.
Using bibliometrics, Dr. Khalid El Bairi identified a research gap in Morocco, and felt a responsibility to fill it.
Let's consider the progress that has been made as well as the work that still needs to be done to reach gender equity in our profession.
Dr. Leslie M. Randall, Dr. Mark Stoler, and I explore the decline in cervical cancer incidence which has not corresponded to a decline in deaths from high-risk invasive disease. 
Dr. Jennifer Temel and Dr. Daniel E. Lage discuss building a career in cancer symptom management research.
If luck, as Louis Pasteur noted, favors the prepared mind, how will oncologists not only prepare but extend cognitive capacity in an era where both medical knowledge and the scope of human endeavor that physicians must address continue to increase exponentially?
Despite limitations, some winds of change are noticeable regarding clinical research in the Latin America and Caribbean region, according to Dr. Matías Chacón, Dr. Diego Enrico, and Dr. Federico Waisberg.
"It is my hope that 10 years from now we will look back on this time—one in which the pandemic laid bare glaring inequities in health care—as an inflection point," said Michael Burton.
"2020 will be a year we at CancerLinQ look back on with mixed emotion because, in the midst of the pandemic, we achieved a momentous milestone," said Dr. Danielle Potter.
Every day in clinic, Dr. Narjust Duma is reminded of the importance of sexual health in cancer care. 
I interviewed Dr. Lawrence with the hope that others will be inspired by his groundbreaking work in international trial design.
Peer review, writes Dr. Yara Abdou, is not a task, but a privilege, and an invaluable experience for the reviewer to enhance their critical thinking and engage in an invigorating academic community.
A spirit of clinically relevant discovery and accessible, understandable knowledge dissemination is the profound legacy, responsibility, and obligation that Rich will leave at ASCO, and we will honor him by continuing this work at the level of rigor and quality he established.
By holding its scientific program on time, ASCO and the entire oncology community make a pledge that we will continue advancing and offering the best care for our patients worldwide. 
We have an urgent need to learn more about how COVID-19 is directly and indirectly affecting the people with cancer whom we serve.
The number of new and old agents being suggested as COVID-19 therapies seems to be expanding exponentially. Dr. Donald L. Trump, Dr. Courtney W. Houchen, and Dr. Milton L. Brown highlight current investigations.
The TMPRSS2 protein has a role in both COVID-19 and in prostate cancer, suggesting intriguing avenues of inquiry for researchers engaged in the fight against COVID-19.

Pages


Advertisement